Google
Trusted Resources: News & Events
Latest announcements and gatherings
Capitol Hill Briefing Held to Encourage Sickle Cell Research and Treatment
Earlier today, a briefing was hosted on Capitol Hill to highlight advancements in sickle cell disease (SCD) research and treatment options.
The briefing was hosted by the American Society for Blood and Marrow Transplantation (ASBMT), American Society of Hematology (ASH), American Society for Gene & Cell Therapy, National Marrow Donor Program/Be the Match, Sickle Cell Disease Association of America, Inc. and Pediatric Hospital Sickle Cell Collaborative, in partnership with The House Research & Development Caucus, the Congressional Caucus to Cure Blood Cancers and Other Blood Disorders and the Congressional Sickle Cell Disease Caucus. Three prominent members of congress – Doris Matsui (CA-6), Bill Foster, PhD (IL-11) and Danny Davis (IL-7) – also participated.
+myBinderRelated Content
-
Emmaus Life Sciences, Inc. to present results of phase 3 study of endariTM (L-glutamine oral powder) at 59th America...Emmaus will present results of a Phase 3...
-
Bluebird Bio Presents Data From LentiGlobin Gene Therapy TrialBluebird Bio’s investigational gene th...
-
Comparative Cost Analysis of Therapy in Sickle Cell Anemia: Supportive Care Vs. Bone Marrow TransplantObjective: A comparative cost analysis o...
-
Hemoglobinopathy Counselor Training Course – VIRTUALUPDATE! 2020 Hemoglobinopathy Counselor ...
-
The use of cannabis by patients with sickle cell disease increased the frequency of hospitalization due to vaso-occl...Introduction: The objective of this stu...
-
Discovery could help treatments for sickle cell diseaseResearch team establishes biomarkers for...
-
SCDAA News Advisory: Partial Hold on Gene Therapy TrialOn December 20, the FDA placed a partial...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.